UNSPSC 51285401: Cefaloram

This classification denotes a cephalosporin antibiotic with the molecular formula C18H18N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) K3086GQJ9Z, chemically known as (6r,7r)-3-(acetoxymethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure but more generally known as cefaloram, which bears US NIH Compound Identifier 68940. European Medicines Agency schedules Cefaloram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06168MIG.

UNSPSC 51285401 Cefaloram, a Commodity code, shows minimal alignment between its nominal pharmaceutical product scope and the recent state and local opportunities tagged under it. The two most recent opportunities posted to this code involve Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets (Illinois Department of Public Health piggyback pharmaceutical warehouse contract awarded to Chartwell Rx LLC in August 2026) and Naloxone and Drug Deactivation Systems (Seminole County, Florida IFB posted in June 2026), neither of which are cefaloram. State and local procurement offices appear to use this code inconsistently or as a catch-all for pharmaceutical supply contracts that do not fit narrower product lines, rather than for the specific antibiotic indicated by the code name.

The issuing bodies soliciting under this code include state health departments and county governments with public health missions. Geographic recent activity centers on Illinois and Florida, based on the two posted opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 contract over 12 months with two renewal options for antibiotic tablets through an Invitation for Bid process; Seminole County released an IFB on June 30, 2026 (due July 26, 2023, a date inconsistent with the posting date) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. Neither opportunity explicitly requires set-asides for disadvantaged business enterprises or veteran-owned businesses. Vendors bidding under this code should expect pharmaceutical supply contracts tied to public health emergency preparedness and community health initiatives rather than cefaloram specifically.